4.4 Article

Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease

Journal

EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 239, Issue 11, Pages 1524-1530

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1535370214523890

Keywords

Vitamin D; inflammatory bowel disease; microbiota

Funding

  1. National Institutes of Health/National Institutes of Neurologic and Stroke [NS067563]
  2. National Center for Complementary and Alternative Medicine
  3. Office of Dietary Supplements [AT005378]

Ask authors/readers for more resources

The inflammatory bowel diseases are complex diseases caused by environmental, immunological, and genetic factors. Vitamin D status is low in patients with inflammatory bowel diseases, and experimental inflammatory bowel diseases are more severe in vitamin D-deficient or vitamin D receptor knockout animals. Vitamin D is beneficial in inflammatory bowel diseases because it regulates multiple checkpoints and processes essential for homeostasis in the gut. Vitamin D inhibits IFN-gamma and IL-17 production while inducing regulatory T cells. In addition, vitamin D regulates epithelial cell integrity, innate immune responses, and the composition of the gut microbiota. Overall, vitamin D regulates multiple pathways that maintain gastrointestinal homeostasis. The data support improving vitamin D status in patients with inflammatory bowel diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available